Full-Time
Lead AI Software Engineer
Posted on 9/9/2026
Humana
10,001+ employees
Medicare Advantage health insurer for seniors
Compensation Overview
$129.3k - $177.8k/yr
Louisville, KY, USA + 4 more
More locations: Nashville, TN, USA | Tampa, FL, USA | Dallas, TX, USA | Fort Lauderdale, FL, USA
Hybrid
Several days on-site per week are required.
 Software Engineering (1) |
|---|
Get referred to Humana
See people who can refer or advise you
- At least 8 years of software engineering experience with demonstrated technical leadership.
- Proven experience building and delivering large-scale, production-grade software platforms.
- Strong backend development expertise with Python, Java, or similar languages.
- Experience designing distributed systems and cloud-native applications.
- Demonstrated ability to lead technical initiatives from architecture through deployment.
- Experience working in agile environments with frequent delivery and iteration.
- Serve as the technical lead for strategic artificial intelligence initiatives, driving architecture, design decisions, and engineering excellence.
- Design and build scalable, secure, cloud-native artificial intelligence platforms and services.
- Architect solutions leveraging generative artificial intelligence, large language models, intelligent document processing, and data-driven applications.
- Lead design reviews, code reviews, and technical planning efforts.
- Establish engineering standards, reusable frameworks, and best practices that enable teams to deliver at scale.
- Provide technical guidance across the full software development lifecycle.
- Build end-to-end artificial intelligence solutions, including application programming interfaces, microservices, data pipelines, orchestration layers, and evaluation frameworks.
- Develop production-grade applications integrating artificial intelligence and machine learning capabilities.
- Partner with platform, infrastructure, and DevOps teams to ensure solutions are scalable, reliable, observable, and cost-efficient.
- Drive technical execution from concept through production deployment in an agile delivery environment.
- Evaluate and adopt emerging artificial intelligence technologies to accelerate innovation and business value.
- Mentor and develop software engineers and data scientists through technical coaching and hands-on collaboration.
- Promote best practices in software engineering, artificial intelligence development, cloud architecture, and operational excellence.
- Foster a culture of innovation, accountability, continuous learning, and high-quality execution.
- Help teams balance rapid delivery with long-term maintainability and technical excellence.
- Implement evaluation, testing, and validation frameworks for artificial intelligence-powered applications.
- Support monitoring, performance optimization, and incident response for artificial intelligence systems in production.
- Drive responsible artificial intelligence practices focused on reliability, security, compliance, and risk management.
- Ensure artificial intelligence solutions meet enterprise standards for scalability, operational readiness, and governance.
- Hands-on experience building and deploying artificial intelligence, machine learning, or generative artificial intelligence solutions in production.
- Experience with large language models and modern artificial intelligence application architectures.
- Knowledge of artificial intelligence orchestration frameworks, agent-based systems, and model-serving platforms.
- Experience with Google Cloud Platform, Amazon Web Services, or Microsoft Azure cloud platforms.
- Familiarity with retrieval-augmented generation, embeddings, vector databases, semantic search, optical character recognition, and intelligent document processing.
- Background in data engineering, data science, or machine learning operations.
- Experience building application programming interfaces, microservices, and event-driven architectures.
- Experience operating within complex or highly regulated enterprise environments.
- Strong communication and stakeholder management skills.
Humana focuses on health and well-being by offering Medicare Advantage plans (HMO, PPO, and PFFS) mainly for seniors, military personnel, and communities. Its products are health insurance plans funded through a mix of government contracts and member premiums, enrolling members to provide comprehensive coverage with flexible benefits and a broad provider network. Members receive care through a network of providers, with additional services such as free language interpretation to improve accessibility. Humana differentiates itself through its emphasis on inclusivity, accessibility, and tailored benefits, aiming to deliver reliable service and high renewal rates. The goal is to improve health outcomes and overall well-being for members by delivering coverage that meets diverse needs and making care accessible to all.
Company Size
10,001+
Company Stage
IPO
Headquarters
Louisville, Kentucky
Founded
1961
Get referred to Humana
See people who can refer or advise you
Simplify's Take
What believers are saying
- Second-quarter 2026 revenue reached $40.87 billion, up 26.2%, beating estimates.
- Illinois awarded Humana a statewide Medicaid contract starting January 2027, broadening state footing.
- Humana expects 2027 MA membership growth of roughly 25%, despite plan exits.
What critics are saying
- CMS star-rating losses cut 2026 GAAP EPS guidance to at least $6.52.
- 2027 plan exits hit 600,000 members, risking churn and weaker brand trust.
- Texas appeal loss or further CMS downgrades can erase billions in MA bonuses.
What makes Humana unique
- Humana leads Medicare Advantage with 6.45 million individual MA members in 2026.
- CenterWell and Medicaid expansion add care delivery and government-contract diversification beyond insurance.
- August 2026 board adds Anthropic's Paul Smith, signaling faster AI-enabled care operations.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Paid Vacation
Paid Parental Leave
Short-term Disability
Long-term Disability
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Growth & Insights and Company News
6 month growth
↑ 6%1 year growth
↑ 6%2 year growth
↑ 6%Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.
Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.
Humana reported Q2 revenues of $40.87 billion, up 26.2% year on year, exceeding analysts' expectations by 0.6%. The health insurance provider also beat earnings per share estimates. Despite the relatively strong results, Humana's stock has fallen 2.7% since the earnings announcement and currently trades at $378.11. The health insurance sector as a whole showed resilience in Q2, with the 12 tracked providers beating revenue consensus estimates by 2.8% on average. However, share prices across the sector have declined an average of 5.8% since reporting. Humana derives over 80% of its revenue from federal government contracts and serves approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.
Nearly 3 million older Americans will lose their Medicare Advantage plans this year, according to Johns Hopkins Bloomberg School of Public Health research. One in 10 Medicare Advantage policyholders face forced disenrollment, with Vermont hit hardest at 92% of policyholders affected. Humana announced its exit from multiple markets for the second consecutive year, impacting 600,000 members. The company reported $1.9 billion profit in the first half of 2026. Insurers cite financial pressures from federal policy changes aimed at reducing overpayments, resulting in lower government reimbursement rates. Combined with rising medical costs, these factors are squeezing profit margins. Shannon Benton of Senior Citizens League said Humana's decision shows Medicare Advantage insurers are "prioritising profit growth over enrollment growth.
Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.